Re: CML Meeting in Ireland

[Guest guest]

At 11:41 AM 5/1/05 -0400, you wrote:

>Hello All,

>

>Suzan McNamara and I have been invited to attend a CML patient meeting in

>Ireland that is being sponsored entirely by Novartis.

This sounds great Cheryl-Anne and Suzan.

I will think about questions I might have.

I think that the drug scene for CML might get kind of interesting with

Novartis very likely having some competitors soon. It looks like BMS is

heading to be fast tracked....and down the road, the competition might be

which is better, the new 'super Gleevec' (AMN107) or the BMS drug????

Interesting times ahead.

Maui Nanc

[Guest guest]

Hi Cheryl,

That is very exciting for you and Suzan.

As you are aware, I attended and participated in the first two conferences

(Zurich and Milan).

Novartis has again invited me to participate in this years conference.

Zavie

[Guest guest]

hallo cheryl anne

i look forward to see you in dublin next month. since i have participated in the

first 2 meetings (last year in milan and the year before in swizerland) i am

sure you will find the meeting very informative and interesting. and above all

its a great pleasure to meet with old internet pals like susan, you, jan from

germany, my long time pal zavie, elizabeth and sandy and more.

shalom

giora

[ ] CML Meeting in Ireland

Hello All,

Suzan McNamara and I have been invited to attend a CML patient meeting in

Ireland that is being sponsored entirely by Novartis.

The meeting will take place on June 17 to the 19th in Dublin Ireland. The

conference is called " New Horizons in Treating Cancer, Third International

Conference for Organizations Representing People with CML or GIST.

The goal of the this conference is to provide patient group representatives

with an opportunity to build relationships and alliances, and to share

experiences and achievements with each other. Last year, more than 35

patient group representatives from 16 countries participated.

At the conference, we will have the opportunity to network with other

patient organizations, to share success stories on a range of topics,

including starting and running a patient group, understanding the clinical

trial process, and influencing health authority decisions on access to

treatment.

Additionally, leading cancer specialists will provide an overview of the

latest research and the impact of this research on targeted therapy for

cancers including chronic myeloid leukemia and gastrointestinal stromal

tumor.

We will be bringing a DVD copy of the webcast to share with other members

there and we wish to share information on our regular meetings and learn how

to expand our group and reach more CML patients. On the subject of the

latter, we will be working with the LLS in Canada to reach more CML patients

and provide them with an opportunity to participate in discussion groups in

Canada.

However, Suzan and I really want to make sure that we also address any

question's you may have regarding CML and specifically if you have any

questions about Gleevec, or the other drugs as there will be CML medical

experts there.

We are both very excited about meeting with patient group leaders from the

various participating countries.

Please do not hesitate to contact me and I will be sure to gather everyone's

questions and return with answers.

We'll also be happy to provide you with a complete report on our return.

Cheers,

Cheryl-Anne and Suzan